Bridgefront Capital, LLC Karyopharm Therapeutics Inc. Transaction History

Bridgefront Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.91 - $14.38 $144,180 - $350,814	-24,396 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.21 - $8.61 $17,974 - $29,704	3,450 Added 16.47%	24,396 $157,000
Q3 2021 Nov 12, 2021	BUY	$4.45 - $10.63 $93,209 - $222,655	20,946 New	20,946 $122,000
Q2 2021 Aug 12, 2021	SELL	$8.11 - $11.11 $303,159 - $415,302	-37,381 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $220,521 - $396,043	22,388 Added 149.32%	37,381 $393,000
Q4 2020 Feb 12, 2021	BUY	$14.15 - $17.19 $212,150 - $257,729	14,993 New	14,993 $232,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $70.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.